News W2O acquisitions continue as it buys Radius Digital Science W2O has made its third acquisition in recent months, buying Radius Digital Science, a New Jersey-based scientific creative agency.
News Ultragenyx to slash costs after Angelman trial failure Ultragenyx's therapy for the rare genetic disorder Angelman syndrome, apazunersen, has flunked a late-stage trial, crashing its share price.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.